Table 1

 Participant data showing sex, sighting dominance, duration of monovision wear (months), and wear pattern as full time (FT) or part-time (PT)

NoSexDominant eyeDuration (months)Dominant eye (distance corrected)Non-dominant eye (near corrected)Anisometropia (SER(dist) − SER(near)) (D)
VCD(dist) (mm)SER(dist) (D)VCD(near) (mm)SER(near) (D)
BaselineAfter MVBaselineAfter MVFinalBaselineAfter MVBaselineAfter MVFinalBaselineAfterMVFinal
Biometric data for each eye of each participant shows vitreous chamber depths (VCD) at baseline and following monovision wear (after MV) and spherical equivalent refractive error (cycloplegic SER) at baseline, following monovision wear (after MV) and following 9–18 months of conventional spectacle wear (Final, non-cycloplegic). Anisometropia (right columns) is absolute value in each case.
1FRE30 (PT)17.4718.33−1.50−3.38−3.1317.4518.01−1.56−3.13−3.130.060.250.00
2FRE29 (FT)16.5217.12−1.69−3.56−3.8816.5217.10−2.31−3.94−4.000.620.380.12
3MRE28 (FT)16.9517.37−1.38−3.00−3.7516.9817.23−1.25−2.13−3.500.130.870.25
4MLE26 (FT)17.1918.07−1.56−3.81−4.4817.2017.73−1.81−2.56−4.000.251.250.38
5FLE23 (PT)15.9816.60−0.61−1.38−2.2516.0416.53−0.86−1.63−2.380.250.250.13
6FRE18 (PT)16.6617.05−3.19−4.25−4.6316.6017.00−3.19−4.06−4.330.000.190.30
7FRE16 (FT)18.4218.64−2.25−3.38−3.2518.3518.40−2.38−2.56−2.750.130.820.50
8MLE16 (FT)17.3117.57−1.56−2.13−2.0017.3917.29−1.81−1.44−1.500.250.690.50
9MRE15 (FT)17.5417.99−1.75−2.56−2.7517.4617.81−1.44−2.00−2.750.310.560.00
10FRE13 (FT)16.9017.35−1.70−3.10−3.0016.8816.99−1.13−1.18−2.750.571.920.25
11FRE12 (FT)16.2216.35−1.13−1.19−2.0016.0716.03−1.25−1.13−1.750.120.060.25
12FLE9 (FT)17.2217.58−1.64−2.44−3.0017.3017.48−2.13−2.38−2.630.490.060.37
13MRE8 (PT)16.9317.07−1.00−1.44−1.8316.9616.99−0.88−1.31−1.750.120.130.08
mean18.717.0217.47−1.61−2.74−3.0717.0217.28−1.69−2.27−2.860.250.570.24
SD7.90.630.660.620.980.910.630.630.670.980.910.200.540.17